Key Points
- Kevin Mccallion sold 2,693 shares of 908 Devices on April 10 at an average price of $7.01 for about $18,878, reducing his stake by 5.66% to 44,925 shares; the transaction was executed under a pre-arranged Rule 10b5-1 plan.
- Company performance and outlook: 908 Devices reported Q results that beat estimates (revenue $17.38M vs. $16.19M; EPS -$0.05 vs. -$0.06), has a market cap of ~$273.6M and P/E of 13.31, and carries a consensus "Moderate Buy" with a $12 target.
908 Devices Inc. (NASDAQ:MASS - Get Free Report) SVP Kevin Mccallion sold 2,693 shares of 908 Devices stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $7.01, for a total value of $18,877.93. Following the completion of the sale, the senior vice president owned 44,925 shares of the company's stock, valued at $314,924.25. The trade was a 5.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
908 Devices Price Performance
MASS stock opened at $7.32 on Wednesday. The business has a 50-day moving average price of $6.51 and a 200 day moving average price of $6.65. The company has a market capitalization of $273.62 million, a P/E ratio of 13.31 and a beta of 0.54. 908 Devices Inc. has a 1-year low of $4.14 and a 1-year high of $9.34.
908 Devices (NASDAQ:MASS - Get Free Report) last released its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.01. The firm had revenue of $17.38 million during the quarter, compared to the consensus estimate of $16.19 million. 908 Devices had a negative return on equity of 14.99% and a net margin of 34.68%. On average, analysts anticipate that 908 Devices Inc. will post -1.99 earnings per share for the current fiscal year.
Hedge Funds Weigh In On 908 Devices
A number of large investors have recently added to or reduced their stakes in MASS. AQR Capital Management LLC bought a new position in 908 Devices in the first quarter worth about $365,000. Geode Capital Management LLC grew its stake in shares of 908 Devices by 11.7% during the second quarter. Geode Capital Management LLC now owns 658,603 shares of the company's stock worth $4,697,000 after acquiring an additional 68,764 shares during the last quarter. Rhumbline Advisers grew its stake in shares of 908 Devices by 5.5% during the second quarter. Rhumbline Advisers now owns 36,416 shares of the company's stock worth $260,000 after acquiring an additional 1,894 shares during the last quarter. American Century Companies Inc. grew its stake in shares of 908 Devices by 22.9% during the second quarter. American Century Companies Inc. now owns 56,296 shares of the company's stock worth $401,000 after acquiring an additional 10,482 shares during the last quarter. Finally, Walleye Capital LLC purchased a new stake in shares of 908 Devices during the second quarter worth about $82,000. 88.06% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. Wall Street Zen upgraded shares of 908 Devices from a "hold" rating to a "buy" rating in a report on Saturday, March 14th. Weiss Ratings upgraded shares of 908 Devices from a "sell (d+)" rating to a "hold (c-)" rating in a report on Monday. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $12.00.
Check Out Our Latest Analysis on 908 Devices
About 908 Devices
(
Get Free Report)
908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company's core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.
Key products in 908 Devices' portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
